Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Chi Sheng Pharma & Biotech Co OCF Yield %?
Chi Sheng Pharma & Biotech CoROCO:4111 +0.33%84 OCF Yield % is 15.12 as of Jul. 15, 2026, which is 43% above its 10-year median of 10.55. GuruFocus rates ROCO:4111 with a GF Score™ of 84/100 and a GF Value™ of NT$33.14 (Fairly Valued). The stock has 1 warning sign investors should review. Among 852 Medical Devices & Instruments companies, Chi Sheng Pharma & Biotech Co ranks better than 93.54% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Chi Sheng Pharma & Biotech Co's OCF Yield % or its related term are showing as below:
ROCO:4111'
s OCF Yield % Range Over the Past 10 Years
Min: 2.67 Med: 10.55 Max: 16.6
Current: 15.12
During the past 13 years, the highest OCF Yield % of Chi Sheng Pharma & Biotech Co was 16.60%. The lowest was 2.67%. And the median was 10.55%.
ROCO:4111's OCF Yield % is ranked better than 93.54% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.695
vs ROCO:4111: 15.12
Chi Sheng Pharma & Biotech Co OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Chi Sheng Pharma & Biotech Co OCF Yield % Related Terms
Chi Sheng Pharma & Biotech Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4111 vs ISRG, BDX, MDLN: OCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Chi Sheng Pharma & Biotech Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chi Sheng Pharma & Biotech Co OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Chi Sheng Pharma & Biotech Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Chi Sheng Pharma & Biotech Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chi Sheng Pharma & Biotech Co (ROCO:4111) has a OCF Yield % of 15.12 as of Jul. 15, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Chi Sheng Pharma & Biotech Co and its competitors. This is 43% above median its historical median of 10.55. Over the past decade, Chi Sheng Pharma & Biotech Co's OCF Yield % has ranged from 2.67 to 16.60. According to the industry distribution chart, Chi Sheng Pharma & Biotech Co ranks #55 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 6.5%.
Is Chi Sheng Pharma & Biotech Co's OCF Yield % too high?
Chi Sheng Pharma & Biotech Co's current OCF Yield % of 15.12 is 43% above median its 10-year median of 10.55. Over the past 10 years, this metric has ranged from a low of 2.67 to a high of 16.60. The Medical Devices & Instruments industry median OCF Yield % is 1.70. Chi Sheng Pharma & Biotech Co's value of 15.12 is 792% above this industry median. Based on the distribution chart, Chi Sheng Pharma & Biotech Co ranks #55 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Chi Sheng Pharma & Biotech Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chi Sheng Pharma & Biotech Co's OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Chi Sheng Pharma & Biotech Co ranks #55 out of 852 companies for OCF Yield %. This places Chi Sheng Pharma & Biotech Co in the top 7% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.70. Chi Sheng Pharma & Biotech Co's value of 15.12 is 792% above this benchmark. Historically, Chi Sheng Pharma & Biotech Co's own OCF Yield % has ranged from 2.67 to 16.60 over the past decade. While the company's 10-year median is 10.55 vs. the industry median of 1.70, Chi Sheng Pharma & Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.70, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chi Sheng Pharma & Biotech Co's current OCF Yield % of 15.12 is 792% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Chi Sheng Pharma & Biotech Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chi Sheng Pharma & Biotech Co's current OCF Yield % is 15.12, which is 43% above median its own 10-year median of 10.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chi Sheng Pharma & Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Chi Sheng Pharma & Biotech Co (ROCO:4111) is currently considered Fairly Valued. The stock's GF Value™ is NT$33.14, compared to a current price of NT$30.15 — trading 9% below its estimated fair value. The current OCF Yield % is 15.12, which is 43% above median its 10-year median of 10.55 and 792% above the Medical Devices & Instruments industry median of 1.70. Chi Sheng Pharma & Biotech Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Chi Sheng Pharma & Biotech Co (ROCO:4111), the current OCF Yield % is 15.12 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chi Sheng Pharma & Biotech Co (ROCO:4111) Overvalued in 2026?
Based on GuruFocus' analysis, Chi Sheng Pharma & Biotech Co stock appears to be undervalued.
The current stock price of NT$30.15 is trading 9% below its estimated GF Value™ of NT$33.14.
GuruFocus considers Chi Sheng Pharma & Biotech Co to be Fairly Valued.
Key valuation signals for ROCO:4111:
OCF Yield %: 15.12 (43% above median its 10-year median of 10.55)
GF Value™: NT$33.14 vs. price of NT$30.15 (9% below fair value)
Industry Position: 792% above the Medical Devices & Instruments median (#55 of 852)
No single metric tells the full story. See the ROCO:4111 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chi Sheng Pharma & Biotech Co Business Description
Chi Sheng Pharma & Biotech Co Ltd manufactures and distributes medical medicines and equipment in Taiwan. It offers injections, including hemodialysis solutions, amino acid injections, vitamin injections, and externally applied medicines.
84GF Score
Get the complete analysis for ROCO:4111
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4111 has been successfully added to your 
